We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EC Accuses J&J, Novartis of Pay-for-Delay on Fentanyl
EC Accuses J&J, Novartis of Pay-for-Delay on Fentanyl
February 12, 2013
The European Commission (EC) accused Johnson & Johnson (J&J) and Novartis of anticompetitive “pay-for-delay” agreements between their respective Dutch subsidiaries on fentanyl.